SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

L773:1096 8652
 

Search: L773:1096 8652 > Royal Institute of Technology > Decreased survival ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase

Jakobsen Falk, Ingrid (author)
Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet
Fyrberg, Anna (author)
Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet
Paul, Esbjörn (author)
Karolinska Institutet, Stockholm, Sweden
show more...
Nahi, Hareth (author)
Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden
Hermanson, Monica (author)
Uppsala universitet,Medicinsk genetik
Rosenquist, Richard Brandell (author)
Uppsala universitet,Hematologi och immunologi
Höglund, Martin (author)
Uppsala universitet,Hematologi
Palmqvist, Lars, 1965 (author)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin,Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine,University of Gothenburg, Sweden
Stockelberg, Dick, 1950 (author)
Sahlgrenska University Hospital, Gothenburg, Sweden
Wei, Yuan, 1978 (author)
Sahlgrenska University Hospital, Gothenburg, Sweden
Gréen, Henrik (author)
KTH,Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet,Genteknologi,Science for Life Laboratory, SciLifeLab
Lotfi, Kourosh (author)
Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet,Klinisk farmakologi
show less...
 (creator_code:org_t)
2013-09-09
2013
English.
In: American Journal of Hematology. - : John Wiley & Sons. - 0361-8609 .- 1096-8652. ; 88:12, s. 1001-1006
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • De novo acute myeloid leukemia with normal karyotype (NK-AML) comprises a large group of patients with no common cytogenetic alterations and with a large variation in treatment response. Single-nucleotide polymorphisms (SNPs) in genes related to the metabolism of the nucleoside analogue AraC, the backbone in AML treatment, might affect drug sensitivity and treatment outcome. Therefore, SNPs may serve as prognostic biomarkers aiding clinicians in individualized treatment decisions, with the aim of improving patient outcomes. We analyzed polymorphisms in genes encoding cytidine deaminase (CDA 79A>C rs2072671 and −451C>T rs532545), 5′-nucleotidase (cN-II 7A>G rs10883841), and deoxycytidine kinase (DCK 3′UTR 948T>C rs4643786) in 205 de novo NK-AML patients. In FLT3-internal tandem duplication (ITD)-positive patients, the CDA 79C/C and −451T/T genotypes were associated with shorter overall survival compared to other genotypes (5 vs. 24 months, P < 0.001 and 5 vs. 23 months, P = 0.015, respectively), and this was most pronounced in FLT3-ITD-positive/NPM1-positive patients. We observed altered in vitro sensitivity to topoisomerase inhibitory drugs, but not to nucleoside analogues, and a decrease in global DNA methylation in cells carrying both CDA variant alleles. A shorter survival was also observed for the cN-II variant allele, but only in FLT3-ITD-negative patients (25 vs. 31 months, P = 0.075). Our results indicate that polymorphisms in genes related to nucleoside analog drug metabolism may serve as prognostic markers in de novo NK-AML

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

MEDICINE
MEDICIN
Nothing to report

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view